

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of erythrocyte differentiation (GO:0045647) | 6.87915859 |
| 2 | definitive hemopoiesis (GO:0060216) | 5.54411510 |
| 3 | positive regulation of B cell differentiation (GO:0045579) | 5.47021957 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.67207292 |
| 5 | L-phenylalanine catabolic process (GO:0006559) | 4.67207292 |
| 6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.65709339 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.36939539 |
| 8 | L-phenylalanine metabolic process (GO:0006558) | 4.36939539 |
| 9 | pinocytosis (GO:0006907) | 4.35416750 |
| 10 | alpha-linolenic acid metabolic process (GO:0036109) | 4.22246674 |
| 11 | aromatic amino acid family catabolic process (GO:0009074) | 3.76808361 |
| 12 | regulation of B cell differentiation (GO:0045577) | 3.74546868 |
| 13 | response to muramyl dipeptide (GO:0032495) | 3.72988159 |
| 14 | megakaryocyte development (GO:0035855) | 3.72066712 |
| 15 | B cell receptor signaling pathway (GO:0050853) | 3.70652194 |
| 16 | positive thymic T cell selection (GO:0045059) | 3.69552404 |
| 17 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.67541054 |
| 18 | Peyers patch development (GO:0048541) | 3.67541054 |
| 19 | positive regulation of granulocyte differentiation (GO:0030854) | 3.61954915 |
| 20 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.54445410 |
| 21 | response to peptidoglycan (GO:0032494) | 3.51722837 |
| 22 | cysteine metabolic process (GO:0006534) | 3.46375093 |
| 23 | lysine metabolic process (GO:0006553) | 3.43974229 |
| 24 | lysine catabolic process (GO:0006554) | 3.43974229 |
| 25 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.43780242 |
| 26 | bile acid biosynthetic process (GO:0006699) | 3.39078520 |
| 27 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.36675861 |
| 28 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.35701504 |
| 29 | regulation of erythrocyte differentiation (GO:0045646) | 3.34866367 |
| 30 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.30822935 |
| 31 | protein carboxylation (GO:0018214) | 3.29662701 |
| 32 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.29662701 |
| 33 | regulation of cholesterol homeostasis (GO:2000188) | 3.29568750 |
| 34 | glyoxylate metabolic process (GO:0046487) | 3.27850760 |
| 35 | urea cycle (GO:0000050) | 3.19988251 |
| 36 | urea metabolic process (GO:0019627) | 3.19988251 |
| 37 | complement activation, alternative pathway (GO:0006957) | 3.19471588 |
| 38 | kynurenine metabolic process (GO:0070189) | 3.16289508 |
| 39 | glutamate metabolic process (GO:0006536) | 3.15321021 |
| 40 | dosage compensation (GO:0007549) | 3.14595643 |
| 41 | sulfur amino acid catabolic process (GO:0000098) | 3.13532663 |
| 42 | poly(A)+ mRNA export from nucleus (GO:0016973) | 3.12077526 |
| 43 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.06005010 |
| 44 | formation of translation preinitiation complex (GO:0001731) | 3.05022841 |
| 45 | bile acid metabolic process (GO:0008206) | 3.04268534 |
| 46 | regulation of gamma-delta T cell activation (GO:0046643) | 3.01371817 |
| 47 | negative regulation of fibrinolysis (GO:0051918) | 2.99148802 |
| 48 | tryptophan catabolic process (GO:0006569) | 2.97264736 |
| 49 | indole-containing compound catabolic process (GO:0042436) | 2.97264736 |
| 50 | indolalkylamine catabolic process (GO:0046218) | 2.97264736 |
| 51 | nuclear pore complex assembly (GO:0051292) | 2.96253761 |
| 52 | regulation of protein activation cascade (GO:2000257) | 2.94755587 |
| 53 | mature B cell differentiation involved in immune response (GO:0002313) | 2.94662841 |
| 54 | cellular ketone body metabolic process (GO:0046950) | 2.93222354 |
| 55 | cellular modified amino acid catabolic process (GO:0042219) | 2.92055643 |
| 56 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.90178066 |
| 57 | high-density lipoprotein particle remodeling (GO:0034375) | 2.90057863 |
| 58 | negative regulation of granulocyte differentiation (GO:0030853) | 2.87695385 |
| 59 | regulation of triglyceride catabolic process (GO:0010896) | 2.87161987 |
| 60 | phospholipid homeostasis (GO:0055091) | 2.84966430 |
| 61 | short-chain fatty acid metabolic process (GO:0046459) | 2.84344173 |
| 62 | drug catabolic process (GO:0042737) | 2.83512202 |
| 63 | nitrogen cycle metabolic process (GO:0071941) | 2.82900125 |
| 64 | DNA unwinding involved in DNA replication (GO:0006268) | 2.82261212 |
| 65 | cellular hyperosmotic response (GO:0071474) | 2.82126978 |
| 66 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.81264907 |
| 67 | response to host (GO:0075136) | 2.81264907 |
| 68 | response to host defenses (GO:0052200) | 2.81264907 |
| 69 | tryptophan metabolic process (GO:0006568) | 2.81205453 |
| 70 | regulation of complement activation (GO:0030449) | 2.79786320 |
| 71 | response to host immune response (GO:0052572) | 2.79762666 |
| 72 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.79762666 |
| 73 | plasma lipoprotein particle clearance (GO:0034381) | 2.79395695 |
| 74 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.79319034 |
| 75 | homocysteine metabolic process (GO:0050667) | 2.79092260 |
| 76 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.78493455 |
| 77 | positive regulation of lipid catabolic process (GO:0050996) | 2.78457368 |
| 78 | aspartate family amino acid catabolic process (GO:0009068) | 2.77345038 |
| 79 | regulation of leukocyte degranulation (GO:0043300) | 2.76182665 |
| 80 | regulation of monocyte differentiation (GO:0045655) | 2.75983884 |
| 81 | regulation of granulocyte differentiation (GO:0030852) | 2.75397146 |
| 82 | macroautophagy (GO:0016236) | 2.74748217 |
| 83 | mature B cell differentiation (GO:0002335) | 2.74731577 |
| 84 | mannose metabolic process (GO:0006013) | 2.73894027 |
| 85 | tyrosine metabolic process (GO:0006570) | 2.72943166 |
| 86 | regulation of histone H3-K9 methylation (GO:0051570) | 2.72684709 |
| 87 | regulation of fibrinolysis (GO:0051917) | 2.72509828 |
| 88 | immunoglobulin mediated immune response (GO:0016064) | 2.72075787 |
| 89 | regulation of RNA export from nucleus (GO:0046831) | 2.71221719 |
| 90 | reverse cholesterol transport (GO:0043691) | 2.70467625 |
| 91 | positive regulation of fatty acid oxidation (GO:0046321) | 2.70093483 |
| 92 | drug transmembrane transport (GO:0006855) | 2.69948554 |
| 93 | acetyl-CoA metabolic process (GO:0006084) | 2.68384174 |
| 94 | regulation of B cell apoptotic process (GO:0002902) | 2.67359737 |
| 95 | negative regulation of phagocytosis (GO:0050765) | 2.66868734 |
| 96 | negative regulation of sterol transport (GO:0032372) | 2.66394492 |
| 97 | negative regulation of cholesterol transport (GO:0032375) | 2.66394492 |
| 98 | mitotic sister chromatid cohesion (GO:0007064) | 2.65535665 |
| 99 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.63964300 |
| 100 | alpha-amino acid catabolic process (GO:1901606) | 2.62491243 |
| 101 | cholesterol efflux (GO:0033344) | 2.62116524 |
| 102 | positive T cell selection (GO:0043368) | 2.62080487 |
| 103 | amino-acid betaine metabolic process (GO:0006577) | 2.61273103 |
| 104 | thymic T cell selection (GO:0045061) | 2.61037080 |
| 105 | coenzyme catabolic process (GO:0009109) | 2.60970836 |
| 106 | serine family amino acid catabolic process (GO:0009071) | 2.60655770 |
| 107 | aromatic amino acid family metabolic process (GO:0009072) | 2.59556575 |
| 108 | 2-oxoglutarate metabolic process (GO:0006103) | 2.58083694 |
| 109 | acylglycerol homeostasis (GO:0055090) | 2.58009953 |
| 110 | triglyceride homeostasis (GO:0070328) | 2.58009953 |
| 111 | regulation of ARF protein signal transduction (GO:0032012) | 2.57736362 |
| 112 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.57386597 |
| 113 | regulation of mast cell degranulation (GO:0043304) | 2.57195994 |
| 114 | natural killer cell differentiation (GO:0001779) | 2.55877277 |
| 115 | regulation of integrin activation (GO:0033623) | 2.54124209 |
| 116 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.54005124 |
| 117 | interkinetic nuclear migration (GO:0022027) | 2.53885301 |
| 118 | ketone body metabolic process (GO:1902224) | 2.53495473 |
| 119 | cellular amino acid catabolic process (GO:0009063) | 2.52124164 |
| 120 | cellular response to exogenous dsRNA (GO:0071360) | 2.52070254 |
| 121 | DNA duplex unwinding (GO:0032508) | 2.51515690 |
| 122 | ethanol oxidation (GO:0006069) | 2.50570886 |
| 123 | ribosomal small subunit biogenesis (GO:0042274) | 2.50454466 |
| 124 | phospholipid efflux (GO:0033700) | 2.50089894 |
| 125 | dicarboxylic acid catabolic process (GO:0043649) | 2.49426780 |
| 126 | negative regulation of DNA repair (GO:0045738) | 2.49366304 |
| 127 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.47783940 |
| 128 | B cell mediated immunity (GO:0019724) | 2.47040657 |
| 129 | protein localization to endosome (GO:0036010) | 2.46820647 |
| 130 | cellular response to interleukin-4 (GO:0071353) | 2.46451512 |
| 131 | positive regulation of interferon-alpha production (GO:0032727) | 2.45941159 |
| 132 | ribosomal small subunit assembly (GO:0000028) | 2.45490759 |
| 133 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.44659272 |
| 134 | regulation of histone H3-K4 methylation (GO:0051569) | 2.44478006 |
| 135 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.42494949 |
| 136 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.42494949 |
| 137 | modulation by symbiont of host immune response (GO:0052553) | 2.42494949 |
| 138 | positive regulation by symbiont of host defense response (GO:0052509) | 2.42494949 |
| 139 | modulation by symbiont of host defense response (GO:0052031) | 2.42494949 |
| 140 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.42494949 |
| 141 | negative thymic T cell selection (GO:0045060) | 2.42401789 |
| 142 | negative regulation of lipase activity (GO:0060192) | 2.42400441 |
| 143 | protein-lipid complex remodeling (GO:0034368) | 2.41872757 |
| 144 | macromolecular complex remodeling (GO:0034367) | 2.41872757 |
| 145 | plasma lipoprotein particle remodeling (GO:0034369) | 2.41872757 |
| 146 | fatty acid beta-oxidation (GO:0006635) | 2.41242936 |
| 147 | positive regulation of histone H3-K4 methylation (GO:0051571) | 2.40565736 |
| 148 | protein-lipid complex assembly (GO:0065005) | 2.40417087 |
| 149 | exogenous drug catabolic process (GO:0042738) | 2.39931162 |
| 150 | fatty acid transmembrane transport (GO:1902001) | 2.38803144 |
| 151 | bile acid and bile salt transport (GO:0015721) | 2.38634685 |
| 152 | fatty acid oxidation (GO:0019395) | 2.38279063 |
| 153 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.37522161 |
| 154 | nuclear pore organization (GO:0006999) | 2.37403523 |
| 155 | sodium ion export (GO:0071436) | 2.37326078 |
| 156 | DNA geometric change (GO:0032392) | 2.37009153 |
| 157 | ribosome assembly (GO:0042255) | 2.35571070 |
| 158 | thioester biosynthetic process (GO:0035384) | 2.35163535 |
| 159 | acyl-CoA biosynthetic process (GO:0071616) | 2.35163535 |
| 160 | B cell homeostasis (GO:0001782) | 2.35084881 |
| 161 | histone H3-K4 trimethylation (GO:0080182) | 2.34968999 |
| 162 | cholesterol homeostasis (GO:0042632) | 2.34164141 |
| 163 | regulation of translational termination (GO:0006449) | 2.33904033 |
| 164 | pore complex assembly (GO:0046931) | 2.33803261 |
| 165 | lipid oxidation (GO:0034440) | 2.33683162 |
| 166 | T cell homeostasis (GO:0043029) | 2.33653591 |
| 167 | very long-chain fatty acid metabolic process (GO:0000038) | 2.33458553 |
| 168 | sterol homeostasis (GO:0055092) | 2.33458246 |
| 169 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.31940902 |
| 170 | histamine secretion (GO:0001821) | 2.31839184 |
| 171 | folic acid metabolic process (GO:0046655) | 2.31360152 |
| 172 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.31294831 |
| 173 | plasma lipoprotein particle assembly (GO:0034377) | 2.30702686 |
| 174 | regulation of translation in response to stress (GO:0043555) | 2.30450050 |
| 175 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.30213667 |
| 176 | regulation of bile acid biosynthetic process (GO:0070857) | 2.29996578 |
| 177 | fatty acid catabolic process (GO:0009062) | 2.29929605 |
| 178 | histone H3-K9 modification (GO:0061647) | 2.29704467 |
| 179 | monocarboxylic acid catabolic process (GO:0072329) | 2.29097419 |
| 180 | histone H3-K9 methylation (GO:0051567) | 2.28709321 |
| 181 | response to mercury ion (GO:0046689) | 2.28002631 |
| 182 | regulation of lipid catabolic process (GO:0050994) | 2.27383967 |
| 183 | negative regulation of B cell apoptotic process (GO:0002903) | 2.26763140 |
| 184 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.26474324 |
| 185 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.26420337 |
| 186 | regulation of histone H3-K27 methylation (GO:0061085) | 2.25117477 |
| 187 | positive regulation of interferon-beta production (GO:0032728) | 2.24967134 |
| 188 | regulation of fatty acid oxidation (GO:0046320) | 2.24940005 |
| 189 | negative regulation of mRNA processing (GO:0050686) | 2.24810369 |
| 190 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.24053935 |
| 191 | mRNA transcription from RNA polymerase II promoter (GO:0042789) | 2.24046178 |
| 192 | UV protection (GO:0009650) | 2.23448884 |
| 193 | biotin metabolic process (GO:0006768) | 2.23287171 |
| 194 | negative regulation of mRNA metabolic process (GO:1903312) | 2.22720290 |
| 195 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.22449426 |
| 196 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.22135744 |
| 197 | snRNA metabolic process (GO:0016073) | 2.22007770 |
| 198 | positive regulation of B cell activation (GO:0050871) | 2.21341849 |
| 199 | endothelium development (GO:0003158) | 2.20704043 |
| 200 | stress fiber assembly (GO:0043149) | 2.20690972 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.87174816 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.95702959 |
| 3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.27848172 |
| 4 | * MYC_22102868_ChIP-Seq_BL_Human | 4.01944570 |
| 5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.84927285 |
| 6 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.47796326 |
| 7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.39314188 |
| 8 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.25608475 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.84506118 |
| 10 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.75035660 |
| 11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.64940280 |
| 12 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.60691358 |
| 13 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.40350236 |
| 14 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.38616707 |
| 15 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.31213252 |
| 16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.30694002 |
| 17 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.25397886 |
| 18 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.23140818 |
| 19 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.16923497 |
| 20 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.14943592 |
| 21 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.03710968 |
| 22 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.95605893 |
| 23 | MAF_26560356_Chip-Seq_TH1_Human | 1.92242927 |
| 24 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.91139103 |
| 25 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81127267 |
| 26 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.80355335 |
| 27 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.76262245 |
| 28 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.74577306 |
| 29 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.73987597 |
| 30 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.73166764 |
| 31 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.72606400 |
| 32 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.72067878 |
| 33 | UTX_26944678_Chip-Seq_JUKART_Human | 1.71982145 |
| 34 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.71687778 |
| 35 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.71421085 |
| 36 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.70361314 |
| 37 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.69472224 |
| 38 | MYB_26560356_Chip-Seq_TH2_Human | 1.66205004 |
| 39 | MYB_26560356_Chip-Seq_TH1_Human | 1.63327439 |
| 40 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.62062187 |
| 41 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.59306750 |
| 42 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.57180302 |
| 43 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.57159664 |
| 44 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.56165119 |
| 45 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.55683497 |
| 46 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.54859131 |
| 47 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54090543 |
| 48 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.53257386 |
| 49 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.53075180 |
| 50 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.51609648 |
| 51 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.51114573 |
| 52 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.49924886 |
| 53 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.49889964 |
| 54 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.49222162 |
| 55 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.48576909 |
| 56 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.46764878 |
| 57 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.46512030 |
| 58 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.45555340 |
| 59 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.45275492 |
| 60 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.44005149 |
| 61 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.43824017 |
| 62 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.43350475 |
| 63 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.42836640 |
| 64 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.42003820 |
| 65 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.40859637 |
| 66 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.40121120 |
| 67 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.39775734 |
| 68 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.39513929 |
| 69 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.39249986 |
| 70 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.39239965 |
| 71 | MAF_26560356_Chip-Seq_TH2_Human | 1.38064478 |
| 72 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.37725801 |
| 73 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.37668272 |
| 74 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.37495028 |
| 75 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.36782532 |
| 76 | KDM2B_26808549_Chip-Seq_K562_Human | 1.35908375 |
| 77 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.34875348 |
| 78 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32797750 |
| 79 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.32752231 |
| 80 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.30802869 |
| 81 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.29538363 |
| 82 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.28938613 |
| 83 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.24731211 |
| 84 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.24410917 |
| 85 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.24101049 |
| 86 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.24101049 |
| 87 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.22282160 |
| 88 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.22256364 |
| 89 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.22015324 |
| 90 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.21915929 |
| 91 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.21602479 |
| 92 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.21355947 |
| 93 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.20238082 |
| 94 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.19076270 |
| 95 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.18882101 |
| 96 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.18191382 |
| 97 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.17703124 |
| 98 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.17474005 |
| 99 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.15162510 |
| 100 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14926615 |
| 101 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14748856 |
| 102 | GATA1_19941826_ChIP-Seq_K562_Human | 1.13936414 |
| 103 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.13268752 |
| 104 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.12998359 |
| 105 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12445710 |
| 106 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.11366897 |
| 107 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.10767941 |
| 108 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.09078475 |
| 109 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.09023460 |
| 110 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.08792384 |
| 111 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.08593786 |
| 112 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.08114684 |
| 113 | GATA1_22025678_ChIP-Seq_K562_Human | 1.06786832 |
| 114 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.06752710 |
| 115 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06572471 |
| 116 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.06443220 |
| 117 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.06423111 |
| 118 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.06405652 |
| 119 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.06332058 |
| 120 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.05544793 |
| 121 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05483798 |
| 122 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.05147504 |
| 123 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.04008494 |
| 124 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.03856101 |
| 125 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.03152375 |
| 126 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.02633223 |
| 127 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.02479302 |
| 128 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.02472803 |
| 129 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.02331691 |
| 130 | RXR_22108803_ChIP-Seq_LS180_Human | 1.02033746 |
| 131 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.99878045 |
| 132 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.99878045 |
| 133 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.99367297 |
| 134 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.99096624 |
| 135 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.98695025 |
| 136 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.98639964 |
| 137 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.98465350 |
| 138 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.98450340 |
| 139 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.98193697 |
| 140 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.97754057 |
| 141 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.97349968 |
| 142 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.96358088 |
| 143 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.96315402 |
| 144 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.96255989 |
| 145 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.95839186 |
| 146 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.95828927 |
| 147 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.95553765 |
| 148 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.95096719 |
| 149 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.95045674 |
| 150 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.94285384 |
| 151 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.94029911 |
| 152 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.94019048 |
| 153 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.93347821 |
| 154 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.93271152 |
| 155 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.92970316 |
| 156 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.92565527 |
| 157 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.92549561 |
| 158 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92056138 |
| 159 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.91614252 |
| 160 | * GABP_19822575_ChIP-Seq_HepG2_Human | 0.91441468 |
| 161 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.90906342 |
| 162 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.90665710 |
| 163 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.90512322 |
| 164 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.89785513 |
| 165 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.89093660 |
| 166 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.89065771 |
| 167 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.88843733 |
| 168 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.88501634 |
| 169 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.88306921 |
| 170 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.88072396 |
| 171 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.88072396 |
| 172 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.87878481 |
| 173 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.87677234 |
| 174 | GATA2_19941826_ChIP-Seq_K562_Human | 0.87201938 |
| 175 | * ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.83448039 |
| 176 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.82983825 |
| 177 | AR_19668381_ChIP-Seq_PC3_Human | 0.82958131 |
| 178 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.82774712 |
| 179 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.82395792 |
| 180 | TP53_16413492_ChIP-PET_HCT116_Human | 0.81659661 |
| 181 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.81650916 |
| 182 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.81226760 |
| 183 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.80380936 |
| 184 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.79968583 |
| 185 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.77194219 |
| 186 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.75853006 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.48742560 |
| 2 | MP0005360_urolithiasis | 5.07016827 |
| 3 | MP0002396_abnormal_hematopoietic_system | 4.89981725 |
| 4 | MP0005365_abnormal_bile_salt | 4.15778262 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.95149699 |
| 6 | MP0003252_abnormal_bile_duct | 3.43738081 |
| 7 | MP0004808_abnormal_hematopoietic_stem | 3.29272612 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 3.25381314 |
| 9 | MP0008057_abnormal_DNA_replication | 3.22820740 |
| 10 | MP0009840_abnormal_foam_cell | 2.83173008 |
| 11 | MP0005464_abnormal_platelet_physiology | 2.66422982 |
| 12 | MP0010329_abnormal_lipoprotein_level | 2.66142830 |
| 13 | MP0002877_abnormal_melanocyte_morpholog | 2.65354428 |
| 14 | MP0009278_abnormal_bone_marrow | 2.64800719 |
| 15 | MP0005397_hematopoietic_system_phenotyp | 2.51654308 |
| 16 | MP0001545_abnormal_hematopoietic_system | 2.51654308 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.49590842 |
| 18 | MP0003763_abnormal_thymus_physiology | 2.48339950 |
| 19 | MP0005075_abnormal_melanosome_morpholog | 2.31443610 |
| 20 | MP0004859_abnormal_synaptic_plasticity | 2.31128965 |
| 21 | MP0001835_abnormal_antigen_presentation | 2.23806615 |
| 22 | MP0005083_abnormal_biliary_tract | 2.22377198 |
| 23 | MP0009780_abnormal_chondrocyte_physiolo | 2.16427311 |
| 24 | MP0003195_calcinosis | 2.09547181 |
| 25 | MP0003705_abnormal_hypodermis_morpholog | 2.06210778 |
| 26 | MP0002398_abnormal_bone_marrow | 2.01259952 |
| 27 | MP0003690_abnormal_glial_cell | 2.01235362 |
| 28 | MP0010094_abnormal_chromosome_stability | 2.01172634 |
| 29 | MP0003329_amyloid_beta_deposits | 2.00637112 |
| 30 | MP0005332_abnormal_amino_acid | 1.97230431 |
| 31 | MP0003436_decreased_susceptibility_to | 1.96627444 |
| 32 | MP0002118_abnormal_lipid_homeostasis | 1.96243463 |
| 33 | MP0000015_abnormal_ear_pigmentation | 1.92302116 |
| 34 | MP0004130_abnormal_muscle_cell | 1.90773380 |
| 35 | MP0001666_abnormal_nutrient_absorption | 1.88462814 |
| 36 | MP0004185_abnormal_adipocyte_glucose | 1.88061021 |
| 37 | MP0000604_amyloidosis | 1.86606263 |
| 38 | MP0005058_abnormal_lysosome_morphology | 1.84678398 |
| 39 | MP0005076_abnormal_cell_differentiation | 1.83992694 |
| 40 | MP0002138_abnormal_hepatobiliary_system | 1.81674350 |
| 41 | MP0003111_abnormal_nucleus_morphology | 1.78866289 |
| 42 | MP0000685_abnormal_immune_system | 1.73211590 |
| 43 | MP0008007_abnormal_cellular_replicative | 1.69619109 |
| 44 | MP0002166_altered_tumor_susceptibility | 1.69360075 |
| 45 | MP0010352_gastrointestinal_tract_polyps | 1.68678643 |
| 46 | MP0008961_abnormal_basal_metabolism | 1.68383703 |
| 47 | MP0000465_gastrointestinal_hemorrhage | 1.68021611 |
| 48 | MP0003300_gastrointestinal_ulcer | 1.66650150 |
| 49 | MP0000609_abnormal_liver_physiology | 1.64600428 |
| 50 | MP0000689_abnormal_spleen_morphology | 1.59173230 |
| 51 | MP0002420_abnormal_adaptive_immunity | 1.56221483 |
| 52 | MP0000703_abnormal_thymus_morphology | 1.53220798 |
| 53 | MP0004270_analgesia | 1.53185080 |
| 54 | MP0002722_abnormal_immune_system | 1.51597380 |
| 55 | MP0001819_abnormal_immune_cell | 1.51473988 |
| 56 | MP0001800_abnormal_humoral_immune | 1.50410862 |
| 57 | MP0002009_preneoplasia | 1.49788680 |
| 58 | MP0002429_abnormal_blood_cell | 1.49561955 |
| 59 | MP0003172_abnormal_lysosome_physiology | 1.47604992 |
| 60 | MP0000716_abnormal_immune_system | 1.45566886 |
| 61 | MP0001853_heart_inflammation | 1.44931324 |
| 62 | MP0002909_abnormal_adrenal_gland | 1.44862082 |
| 63 | MP0003077_abnormal_cell_cycle | 1.44293358 |
| 64 | MP0003868_abnormal_feces_composition | 1.43068732 |
| 65 | MP0002419_abnormal_innate_immunity | 1.42474725 |
| 66 | MP0005000_abnormal_immune_tolerance | 1.41117888 |
| 67 | MP0005666_abnormal_adipose_tissue | 1.40617460 |
| 68 | MP0000350_abnormal_cell_proliferation | 1.40549111 |
| 69 | MP0004043_abnormal_pH_regulation | 1.40248966 |
| 70 | MP0002452_abnormal_antigen_presenting | 1.39953559 |
| 71 | MP0004019_abnormal_vitamin_homeostasis | 1.35934848 |
| 72 | MP0000920_abnormal_myelination | 1.34105843 |
| 73 | MP0002019_abnormal_tumor_incidence | 1.32621932 |
| 74 | MP0010234_abnormal_vibrissa_follicle | 1.32564230 |
| 75 | MP0002723_abnormal_immune_serum | 1.29354016 |
| 76 | MP0005167_abnormal_blood-brain_barrier | 1.26106183 |
| 77 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.24565059 |
| 78 | MP0005409_darkened_coat_color | 1.19825699 |
| 79 | MP0005375_adipose_tissue_phenotype | 1.18983079 |
| 80 | MP0005670_abnormal_white_adipose | 1.17643318 |
| 81 | MP0005174_abnormal_tail_pigmentation | 1.17550282 |
| 82 | MP0002006_tumorigenesis | 1.16992231 |
| 83 | MP0005025_abnormal_response_to | 1.15820605 |
| 84 | MP0003075_altered_response_to | 1.14740175 |
| 85 | MP0009643_abnormal_urine_homeostasis | 1.14725027 |
| 86 | MP0003806_abnormal_nucleotide_metabolis | 1.14606883 |
| 87 | MP0003566_abnormal_cell_adhesion | 1.14293227 |
| 88 | MP0000371_diluted_coat_color | 1.13186766 |
| 89 | MP0003633_abnormal_nervous_system | 1.11898778 |
| 90 | MP0003635_abnormal_synaptic_transmissio | 1.11722666 |
| 91 | MP0005621_abnormal_cell_physiology | 1.11390808 |
| 92 | MP0004957_abnormal_blastocyst_morpholog | 1.10032879 |
| 93 | MP0008058_abnormal_DNA_repair | 1.09449994 |
| 94 | MP0002405_respiratory_system_inflammati | 1.08121962 |
| 95 | MP0001730_embryonic_growth_arrest | 1.07948976 |
| 96 | MP0005451_abnormal_body_composition | 1.07436751 |
| 97 | MP0002078_abnormal_glucose_homeostasis | 1.06624178 |
| 98 | MP0003303_peritoneal_inflammation | 1.06132740 |
| 99 | MP0005387_immune_system_phenotype | 1.05539433 |
| 100 | MP0001790_abnormal_immune_system | 1.05539433 |
| 101 | MP0002837_dystrophic_cardiac_calcinosis | 1.05215228 |
| 102 | MP0004381_abnormal_hair_follicle | 1.04851447 |
| 103 | MP0000313_abnormal_cell_death | 1.04319921 |
| 104 | MP0004885_abnormal_endolymph | 1.04231070 |
| 105 | MP0002971_abnormal_brown_adipose | 1.03684263 |
| 106 | MP0005319_abnormal_enzyme/_coenzyme | 1.02356984 |
| 107 | MP0009333_abnormal_splenocyte_physiolog | 1.02080497 |
| 108 | MP0003943_abnormal_hepatobiliary_system | 1.01869700 |
| 109 | MP0000003_abnormal_adipose_tissue | 1.01649818 |
| 110 | MP0001851_eye_inflammation | 1.00843383 |
| 111 | MP0001873_stomach_inflammation | 1.00708737 |
| 112 | MP0003693_abnormal_embryo_hatching | 1.00675075 |
| 113 | MP0000490_abnormal_crypts_of | 1.00289203 |
| 114 | MP0005535_abnormal_body_temperature | 1.00178193 |
| 115 | MP0002064_seizures | 0.97963650 |
| 116 | MP0003984_embryonic_growth_retardation | 0.97826091 |
| 117 | MP0004947_skin_inflammation | 0.97119418 |
| 118 | MP0000681_abnormal_thyroid_gland | 0.96476032 |
| 119 | MP0003828_pulmonary_edema | 0.96413551 |
| 120 | MP0009931_abnormal_skin_appearance | 0.95577449 |
| 121 | MP0005501_abnormal_skin_physiology | 0.95288689 |
| 122 | MP0003045_fibrosis | 0.94678922 |
| 123 | MP0002086_abnormal_extraembryonic_tissu | 0.94120816 |
| 124 | MP0003786_premature_aging | 0.93375943 |
| 125 | MP0005384_cellular_phenotype | 0.92853933 |
| 126 | MP0000747_muscle_weakness | 0.92753730 |
| 127 | MP0004858_abnormal_nervous_system | 0.92382742 |
| 128 | MP0002080_prenatal_lethality | 0.91668665 |
| 129 | MP0001672_abnormal_embryogenesis/_devel | 0.90637941 |
| 130 | MP0005380_embryogenesis_phenotype | 0.90637941 |
| 131 | MP0002088_abnormal_embryonic_growth/wei | 0.90534728 |
| 132 | MP0002090_abnormal_vision | 0.90407299 |
| 133 | MP0001765_abnormal_ion_homeostasis | 0.90303570 |
| 134 | MP0010368_abnormal_lymphatic_system | 0.90108428 |
| 135 | MP0000372_irregular_coat_pigmentation | 0.87898987 |
| 136 | MP0005334_abnormal_fat_pad | 0.87802974 |
| 137 | MP0000013_abnormal_adipose_tissue | 0.87417379 |
| 138 | MP0004510_myositis | 0.86774701 |
| 139 | MP0002796_impaired_skin_barrier | 0.85617228 |
| 140 | MP0001756_abnormal_urination | 0.84629692 |
| 141 | MP0001915_intracranial_hemorrhage | 0.84541581 |
| 142 | MP0002254_reproductive_system_inflammat | 0.83945914 |
| 143 | MP0003631_nervous_system_phenotype | 0.82953470 |
| 144 | MP0002970_abnormal_white_adipose | 0.82443219 |
| 145 | MP0002063_abnormal_learning/memory/cond | 0.82167097 |
| 146 | MP0009115_abnormal_fat_cell | 0.81815439 |
| 147 | MP0004134_abnormal_chest_morphology | 0.81786621 |
| 148 | MP0003634_abnormal_glial_cell | 0.81332412 |
| 149 | MP0008874_decreased_physiological_sensi | 0.80907278 |
| 150 | MP0002060_abnormal_skin_morphology | 0.78608523 |
| 151 | MP0002928_abnormal_bile_duct | 0.78398641 |
| 152 | MP0009379_abnormal_foot_pigmentation | 0.78381842 |
| 153 | MP0002998_abnormal_bone_remodeling | 0.78322440 |
| 154 | MP0003453_abnormal_keratinocyte_physiol | 0.78279782 |
| 155 | MP0002075_abnormal_coat/hair_pigmentati | 0.78100548 |
| 156 | MP0001697_abnormal_embryo_size | 0.77812174 |
| 157 | MP0004782_abnormal_surfactant_physiolog | 0.77788907 |
| 158 | MP0010155_abnormal_intestine_physiology | 0.77232503 |
| 159 | MP0001661_extended_life_span | 0.76822480 |
| 160 | MP0000569_abnormal_digit_pigmentation | 0.75529726 |
| 161 | MP0002148_abnormal_hypersensitivity_rea | 0.75216586 |
| 162 | MP0003656_abnormal_erythrocyte_physiolo | 0.74464495 |
| 163 | MP0000579_abnormal_nail_morphology | 0.72208556 |
| 164 | MP0005448_abnormal_energy_balance | 0.70824886 |
| 165 | MP0003632_abnormal_nervous_system | 0.68830572 |
| 166 | MP0002168_other_aberrant_phenotype | 0.68375818 |
| 167 | MP0000598_abnormal_liver_morphology | 0.66566853 |
| 168 | MP0002229_neurodegeneration | 0.65761517 |
| 169 | MP0009745_abnormal_behavioral_response | 0.64377222 |
| 170 | MP0003183_abnormal_peptide_metabolism | 0.64186250 |
| 171 | MP0001486_abnormal_startle_reflex | 0.64129526 |
| 172 | MP0009642_abnormal_blood_homeostasis | 0.63148197 |
| 173 | MP0000230_abnormal_systemic_arterial | 0.62904029 |
| 174 | MP0002822_catalepsy | 0.62079135 |
| 175 | MP0005636_abnormal_mineral_homeostasis | 0.61496610 |
| 176 | MP0001944_abnormal_pancreas_morphology | 0.60858180 |
| 177 | MP0005220_abnormal_exocrine_pancreas | 0.60222425 |
| 178 | MP0002572_abnormal_emotion/affect_behav | 0.57716547 |
| 179 | MP0003953_abnormal_hormone_level | 0.57684618 |
| 180 | MP0008569_lethality_at_weaning | 0.57558181 |
| 181 | MP0005166_decreased_susceptibility_to | 0.57165157 |
| 182 | MP0002896_abnormal_bone_mineralization | 0.56765722 |
| 183 | MP0000639_abnormal_adrenal_gland | 0.55368797 |
| 184 | MP0002069_abnormal_eating/drinking_beha | 0.54617196 |
| 185 | MP0009046_muscle_twitch | 0.53330652 |
| 186 | MP0001501_abnormal_sleep_pattern | 0.53017215 |
| 187 | MP0002136_abnormal_kidney_physiology | 0.51150587 |
| 188 | MP0010678_abnormal_skin_adnexa | 0.50842363 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 4.81694133 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 4.26110961 |
| 3 | Complement deficiency (HP:0004431) | 4.10214057 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.09600859 |
| 5 | Xanthomatosis (HP:0000991) | 4.07642841 |
| 6 | Acute lymphatic leukemia (HP:0006721) | 3.98847069 |
| 7 | Acute myeloid leukemia (HP:0004808) | 3.76542397 |
| 8 | Agammaglobulinemia (HP:0004432) | 3.68450449 |
| 9 | Thrombocytosis (HP:0001894) | 3.67771516 |
| 10 | Panhypogammaglobulinemia (HP:0003139) | 3.65700310 |
| 11 | Prolonged bleeding time (HP:0003010) | 3.61654599 |
| 12 | Hyperlipoproteinemia (HP:0010980) | 3.55919955 |
| 13 | Ketosis (HP:0001946) | 3.46295435 |
| 14 | Recurrent viral infections (HP:0004429) | 3.30963933 |
| 15 | Ketoacidosis (HP:0001993) | 3.29284018 |
| 16 | Neurofibrillary tangles (HP:0002185) | 3.27703279 |
| 17 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.22917844 |
| 18 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.22497085 |
| 19 | Cellulitis (HP:0100658) | 3.15534141 |
| 20 | Cerebral inclusion bodies (HP:0100314) | 3.07328453 |
| 21 | Epidermoid cyst (HP:0200040) | 3.07195271 |
| 22 | Viral hepatitis (HP:0006562) | 3.05152435 |
| 23 | Hypoglycemic coma (HP:0001325) | 2.90474897 |
| 24 | Gout (HP:0001997) | 2.86171956 |
| 25 | Impaired platelet aggregation (HP:0003540) | 2.80083200 |
| 26 | Abnormal platelet function (HP:0011869) | 2.80083200 |
| 27 | Fatigue (HP:0012378) | 2.77466363 |
| 28 | Systemic lupus erythematosus (HP:0002725) | 2.74899561 |
| 29 | Abnormality of complement system (HP:0005339) | 2.72327239 |
| 30 | Epistaxis (HP:0000421) | 2.71354711 |
| 31 | Thoracic kyphosis (HP:0002942) | 2.70708546 |
| 32 | Hypoalphalipoproteinemia (HP:0003233) | 2.70669780 |
| 33 | Abnormality of the common coagulation pathway (HP:0010990) | 2.67797783 |
| 34 | Hyperammonemia (HP:0001987) | 2.65545182 |
| 35 | Prolonged partial thromboplastin time (HP:0003645) | 2.64078250 |
| 36 | Abnormality of the thoracic spine (HP:0100711) | 2.60752388 |
| 37 | Hypobetalipoproteinemia (HP:0003563) | 2.58824660 |
| 38 | Abnormality of the fingertips (HP:0001211) | 2.57900435 |
| 39 | Broad face (HP:0000283) | 2.55738782 |
| 40 | Recurrent fungal infections (HP:0002841) | 2.54127673 |
| 41 | Abnormality of glycine metabolism (HP:0010895) | 2.54113390 |
| 42 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.54113390 |
| 43 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.53553410 |
| 44 | Skin nodule (HP:0200036) | 2.52385847 |
| 45 | Hyperacusis (HP:0010780) | 2.51677053 |
| 46 | Increased IgE level (HP:0003212) | 2.51334109 |
| 47 | Colitis (HP:0002583) | 2.50101330 |
| 48 | Petechiae (HP:0000967) | 2.49037512 |
| 49 | Gastrointestinal inflammation (HP:0004386) | 2.48797051 |
| 50 | Hyperglycinuria (HP:0003108) | 2.46667150 |
| 51 | Supranuclear gaze palsy (HP:0000605) | 2.46435825 |
| 52 | Spondylolisthesis (HP:0003302) | 2.46068560 |
| 53 | Sensorimotor neuropathy (HP:0007141) | 2.44202880 |
| 54 | Myocardial infarction (HP:0001658) | 2.44100371 |
| 55 | Hypolipoproteinemia (HP:0010981) | 2.43932315 |
| 56 | Abnormal platelet volume (HP:0011876) | 2.42011469 |
| 57 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.39015849 |
| 58 | Hyperglycinemia (HP:0002154) | 2.38746568 |
| 59 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.37187474 |
| 60 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.35368496 |
| 61 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.33701421 |
| 62 | Asymmetry of the thorax (HP:0001555) | 2.33126520 |
| 63 | Autoimmune hemolytic anemia (HP:0001890) | 2.31723806 |
| 64 | Recurrent cutaneous fungal infections (HP:0011370) | 2.30003809 |
| 65 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.30003809 |
| 66 | Hypercholesterolemia (HP:0003124) | 2.28720430 |
| 67 | B lymphocytopenia (HP:0010976) | 2.27687544 |
| 68 | Joint hemorrhage (HP:0005261) | 2.24970554 |
| 69 | Polygenic inheritance (HP:0010982) | 2.24579883 |
| 70 | Turricephaly (HP:0000262) | 2.24055055 |
| 71 | Hypoglycemic seizures (HP:0002173) | 2.23508063 |
| 72 | Meningitis (HP:0001287) | 2.23049293 |
| 73 | Mitral stenosis (HP:0001718) | 2.21572419 |
| 74 | Increased mean platelet volume (HP:0011877) | 2.21502058 |
| 75 | Glomerulonephritis (HP:0000099) | 2.21491160 |
| 76 | Dysostosis multiplex (HP:0000943) | 2.21231105 |
| 77 | Abnormality of B cell number (HP:0010975) | 2.20967734 |
| 78 | Aplastic anemia (HP:0001915) | 2.19952040 |
| 79 | Intention tremor (HP:0002080) | 2.19878623 |
| 80 | Abnormality of purine metabolism (HP:0004352) | 2.19784179 |
| 81 | Retinal atrophy (HP:0001105) | 2.17577121 |
| 82 | Inflammation of the large intestine (HP:0002037) | 2.16736592 |
| 83 | Abnormality of T cell physiology (HP:0011840) | 2.16474068 |
| 84 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.15659121 |
| 85 | Granulocytopenia (HP:0001913) | 2.14004552 |
| 86 | Abnormality of oral frenula (HP:0000190) | 2.13121763 |
| 87 | Progressive muscle weakness (HP:0003323) | 2.10640346 |
| 88 | Axonal loss (HP:0003447) | 2.10438558 |
| 89 | Spinal cord lesions (HP:0100561) | 2.10419742 |
| 90 | Syringomyelia (HP:0003396) | 2.10419742 |
| 91 | Mucopolysacchariduria (HP:0008155) | 2.09067627 |
| 92 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.09067627 |
| 93 | Global brain atrophy (HP:0002283) | 2.09018277 |
| 94 | Action tremor (HP:0002345) | 2.08993430 |
| 95 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.08185303 |
| 96 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.08185303 |
| 97 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.08185303 |
| 98 | Microvesicular hepatic steatosis (HP:0001414) | 2.07514539 |
| 99 | Chronic obstructive pulmonary disease (HP:0006510) | 2.07330093 |
| 100 | Obstructive lung disease (HP:0006536) | 2.07330093 |
| 101 | Ankyloglossia (HP:0010296) | 2.07001600 |
| 102 | Hyperglycemia (HP:0003074) | 2.04808066 |
| 103 | Verrucae (HP:0200043) | 2.04598766 |
| 104 | Papilloma (HP:0012740) | 2.04598766 |
| 105 | Fat malabsorption (HP:0002630) | 2.04232133 |
| 106 | Ocular albinism (HP:0001107) | 2.03747988 |
| 107 | Abnormality of the Achilles tendon (HP:0005109) | 2.03216506 |
| 108 | Progressive external ophthalmoplegia (HP:0000590) | 2.00237455 |
| 109 | Neuronal loss in central nervous system (HP:0002529) | 2.00053238 |
| 110 | Spontaneous hematomas (HP:0007420) | 1.99117938 |
| 111 | Abnormality of the intrinsic pathway (HP:0010989) | 1.98392048 |
| 112 | Macroorchidism (HP:0000053) | 1.98079832 |
| 113 | Deep palmar crease (HP:0006191) | 1.98060052 |
| 114 | Myelodysplasia (HP:0002863) | 1.97859671 |
| 115 | Postural instability (HP:0002172) | 1.97559027 |
| 116 | Hepatitis (HP:0012115) | 1.97179816 |
| 117 | Lymphangioma (HP:0100764) | 1.96745715 |
| 118 | Amyloidosis (HP:0011034) | 1.96027069 |
| 119 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.94378907 |
| 120 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.94356514 |
| 121 | Urethral obstruction (HP:0000796) | 1.94230185 |
| 122 | Conjugated hyperbilirubinemia (HP:0002908) | 1.94226495 |
| 123 | Delayed CNS myelination (HP:0002188) | 1.93537330 |
| 124 | Status epilepticus (HP:0002133) | 1.93449538 |
| 125 | Late onset (HP:0003584) | 1.93212705 |
| 126 | Esophageal varix (HP:0002040) | 1.91824435 |
| 127 | Osteomyelitis (HP:0002754) | 1.90047937 |
| 128 | Hypertensive crisis (HP:0100735) | 1.89909922 |
| 129 | Albinism (HP:0001022) | 1.89819055 |
| 130 | Abnormality of the thymus (HP:0000777) | 1.89646365 |
| 131 | Cerebral aneurysm (HP:0004944) | 1.88776320 |
| 132 | Prominent nose (HP:0000448) | 1.87472714 |
| 133 | Cutis marmorata (HP:0000965) | 1.86698721 |
| 134 | Hemiplegia (HP:0002301) | 1.85871981 |
| 135 | Abnormality of the prostate (HP:0008775) | 1.85668410 |
| 136 | Abnormality of the columella (HP:0009929) | 1.84808137 |
| 137 | Visceral angiomatosis (HP:0100761) | 1.84508809 |
| 138 | Increased CSF protein (HP:0002922) | 1.84057395 |
| 139 | Poikiloderma (HP:0001029) | 1.83624865 |
| 140 | Broad metatarsal (HP:0001783) | 1.83543469 |
| 141 | Termporal pattern (HP:0011008) | 1.82393072 |
| 142 | Insidious onset (HP:0003587) | 1.82393072 |
| 143 | Impaired proprioception (HP:0010831) | 1.80396556 |
| 144 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.78733360 |
| 145 | Increased cerebral lipofuscin (HP:0011813) | 1.78548086 |
| 146 | Flat acetabular roof (HP:0003180) | 1.78511886 |
| 147 | Gingival bleeding (HP:0000225) | 1.78417060 |
| 148 | Hepatocellular carcinoma (HP:0001402) | 1.77479561 |
| 149 | Long eyelashes (HP:0000527) | 1.76606383 |
| 150 | Teleangiectasia of the skin (HP:0100585) | 1.76523250 |
| 151 | Hyperthyroidism (HP:0000836) | 1.76140751 |
| 152 | Spastic tetraparesis (HP:0001285) | 1.75661527 |
| 153 | Peripheral demyelination (HP:0011096) | 1.75317023 |
| 154 | Hemorrhage of the eye (HP:0011885) | 1.74662522 |
| 155 | Thickened calvaria (HP:0002684) | 1.74588617 |
| 156 | Visual hallucinations (HP:0002367) | 1.73926637 |
| 157 | Seborrheic dermatitis (HP:0001051) | 1.73886471 |
| 158 | Pustule (HP:0200039) | 1.73738326 |
| 159 | Neonatal onset (HP:0003623) | 1.73244423 |
| 160 | Trismus (HP:0000211) | 1.73110843 |
| 161 | Hemangiomatosis (HP:0007461) | 1.72979607 |
| 162 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.72305000 |
| 163 | Polycythemia (HP:0001901) | 1.71894647 |
| 164 | Dysmetria (HP:0001310) | 1.71639305 |
| 165 | Deep philtrum (HP:0002002) | 1.69508498 |
| 166 | Spastic gait (HP:0002064) | 1.69445557 |
| 167 | Sparse scalp hair (HP:0002209) | 1.68787438 |
| 168 | Basal cell carcinoma (HP:0002671) | 1.68329105 |
| 169 | Upper limb amyotrophy (HP:0009129) | 1.68184106 |
| 170 | Distal upper limb amyotrophy (HP:0007149) | 1.68184106 |
| 171 | Recurrent abscess formation (HP:0002722) | 1.68095216 |
| 172 | Abnormality of the right ventricle (HP:0001707) | 1.68026656 |
| 173 | Neoplasm of the adrenal cortex (HP:0100641) | 1.67464468 |
| 174 | Nephritis (HP:0000123) | 1.66577974 |
| 175 | Skin ulcer (HP:0200042) | 1.66230031 |
| 176 | Impaired social interactions (HP:0000735) | 1.65238649 |
| 177 | Abnormal social behavior (HP:0012433) | 1.65238649 |
| 178 | Squamous cell carcinoma (HP:0002860) | 1.64398272 |
| 179 | Hyporeflexia of lower limbs (HP:0002600) | 1.64292092 |
| 180 | Gastrointestinal stroma tumor (HP:0100723) | 1.64283185 |
| 181 | Slow saccadic eye movements (HP:0000514) | 1.63556490 |
| 182 | Heterotopia (HP:0002282) | 1.63428495 |
| 183 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.63419811 |
| 184 | Urticaria (HP:0001025) | 1.63166434 |
| 185 | Dysmetric saccades (HP:0000641) | 1.63125678 |
| 186 | Hyperuricemia (HP:0002149) | 1.62930741 |
| 187 | Increased purine levels (HP:0004368) | 1.62930741 |
| 188 | Focal seizures (HP:0007359) | 1.62919188 |
| 189 | Increased circulating renin level (HP:0000848) | 1.62904589 |
| 190 | Torticollis (HP:0000473) | 1.62699829 |
| 191 | Abnormal gallbladder morphology (HP:0012437) | 1.62555728 |
| 192 | Stroke (HP:0001297) | 1.62444221 |
| 193 | Autoimmune thrombocytopenia (HP:0001973) | 1.61934621 |
| 194 | Coarse hair (HP:0002208) | 1.61659717 |
| 195 | Multiple enchondromatosis (HP:0005701) | 1.60125891 |
| 196 | High pitched voice (HP:0001620) | 1.59942234 |
| 197 | Craniofacial hyperostosis (HP:0004493) | 1.59409136 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 3.62062286 |
| 2 | CDK12 | 3.53793689 |
| 3 | PRPF4B | 3.29768163 |
| 4 | MAP2K3 | 3.02566225 |
| 5 | SMG1 | 2.88376541 |
| 6 | SCYL2 | 2.76512540 |
| 7 | KIT | 2.41471427 |
| 8 | ERN1 | 2.39700280 |
| 9 | MAP4K1 | 2.27430674 |
| 10 | SIK1 | 2.21354828 |
| 11 | MAP3K9 | 2.13955945 |
| 12 | FLT3 | 2.10570832 |
| 13 | NME2 | 2.04950306 |
| 14 | CAMK1G | 2.04451969 |
| 15 | FGFR2 | 1.98822364 |
| 16 | RIPK1 | 1.82318265 |
| 17 | DAPK2 | 1.80224468 |
| 18 | CAMK1D | 1.78186300 |
| 19 | BTK | 1.76147656 |
| 20 | KSR2 | 1.70015000 |
| 21 | IRAK3 | 1.70007546 |
| 22 | TAOK3 | 1.69806340 |
| 23 | LATS1 | 1.67179723 |
| 24 | FGFR4 | 1.57938300 |
| 25 | EPHB1 | 1.54688011 |
| 26 | WNK3 | 1.53272578 |
| 27 | CSF1R | 1.51742250 |
| 28 | INSRR | 1.50855126 |
| 29 | RPS6KB2 | 1.50721448 |
| 30 | PAK6 | 1.49816542 |
| 31 | NTRK1 | 1.46989625 |
| 32 | PTK6 | 1.45832556 |
| 33 | TEC | 1.45467674 |
| 34 | WNK4 | 1.45182500 |
| 35 | MAP3K2 | 1.44107459 |
| 36 | MAP3K10 | 1.43733392 |
| 37 | MAP2K4 | 1.42044335 |
| 38 | MAP3K14 | 1.36625341 |
| 39 | TYRO3 | 1.36466321 |
| 40 | PRKD3 | 1.35520882 |
| 41 | CDK6 | 1.34871077 |
| 42 | TBK1 | 1.34325028 |
| 43 | RET | 1.31313761 |
| 44 | EIF2AK3 | 1.31101406 |
| 45 | PKN2 | 1.30101158 |
| 46 | PRKCH | 1.29684154 |
| 47 | CDK4 | 1.26461995 |
| 48 | EPHA4 | 1.26173337 |
| 49 | MAP3K7 | 1.25348524 |
| 50 | SYK | 1.23421004 |
| 51 | BRD4 | 1.22014791 |
| 52 | BCKDK | 1.20833076 |
| 53 | OXSR1 | 1.20129492 |
| 54 | ICK | 1.19750379 |
| 55 | TGFBR2 | 1.15945159 |
| 56 | ITK | 1.15656688 |
| 57 | ZAP70 | 1.15373195 |
| 58 | PIM2 | 1.14864466 |
| 59 | WNK1 | 1.14538907 |
| 60 | STK39 | 1.13777791 |
| 61 | PRKD2 | 1.12576576 |
| 62 | JAK3 | 1.09407877 |
| 63 | TRPM7 | 1.08668340 |
| 64 | NTRK3 | 1.08273589 |
| 65 | MATK | 1.07015651 |
| 66 | PDGFRA | 1.07002209 |
| 67 | MAP3K3 | 1.06925679 |
| 68 | CDK7 | 1.06056618 |
| 69 | MAPK15 | 1.03942837 |
| 70 | JAK1 | 1.03924758 |
| 71 | STK38 | 1.03840696 |
| 72 | SGK3 | 1.03274712 |
| 73 | MAPK11 | 1.03055718 |
| 74 | TNK2 | 1.02664292 |
| 75 | PDPK1 | 1.01799416 |
| 76 | MAP3K4 | 0.99476226 |
| 77 | MAP3K13 | 0.98638822 |
| 78 | CDC7 | 0.98311690 |
| 79 | CAMKK1 | 0.96869602 |
| 80 | MAP2K2 | 0.96809470 |
| 81 | STK11 | 0.96485300 |
| 82 | RPS6KL1 | 0.96046221 |
| 83 | RPS6KC1 | 0.96046221 |
| 84 | SGK223 | 0.95682276 |
| 85 | SGK494 | 0.95682276 |
| 86 | MARK1 | 0.95610774 |
| 87 | DMPK | 0.93569728 |
| 88 | MET | 0.93214134 |
| 89 | FRK | 0.91242265 |
| 90 | PDGFRB | 0.90834850 |
| 91 | JAK2 | 0.89246054 |
| 92 | RPS6KA2 | 0.87972836 |
| 93 | PHKG1 | 0.86251462 |
| 94 | PHKG2 | 0.86251462 |
| 95 | PDK1 | 0.85592839 |
| 96 | PTK2 | 0.85061004 |
| 97 | HCK | 0.84661851 |
| 98 | PASK | 0.84138645 |
| 99 | SIK2 | 0.83311275 |
| 100 | TAOK1 | 0.82785697 |
| 101 | MARK2 | 0.82462932 |
| 102 | BMPR2 | 0.82360810 |
| 103 | PAK3 | 0.80201728 |
| 104 | PAK2 | 0.79912011 |
| 105 | CDK9 | 0.78823395 |
| 106 | LMTK2 | 0.78534286 |
| 107 | TTN | 0.77428186 |
| 108 | RPS6KA6 | 0.76890583 |
| 109 | IKBKB | 0.76865352 |
| 110 | PRKAA2 | 0.76241098 |
| 111 | NTRK2 | 0.74869211 |
| 112 | CDK5 | 0.74600342 |
| 113 | ATR | 0.73498818 |
| 114 | PRKD1 | 0.73245025 |
| 115 | PKN1 | 0.70244916 |
| 116 | FGFR3 | 0.69593932 |
| 117 | ERBB4 | 0.68739969 |
| 118 | PRKCZ | 0.66755463 |
| 119 | MINK1 | 0.66486092 |
| 120 | MAP3K1 | 0.66375609 |
| 121 | CDK8 | 0.66078321 |
| 122 | IRAK4 | 0.65897071 |
| 123 | PRKAA1 | 0.65365321 |
| 124 | BMX | 0.64474303 |
| 125 | MTOR | 0.64150547 |
| 126 | IRAK2 | 0.63871156 |
| 127 | MAP3K6 | 0.63308308 |
| 128 | LCK | 0.62784327 |
| 129 | GRK6 | 0.62312286 |
| 130 | CHEK1 | 0.61984129 |
| 131 | FES | 0.61244685 |
| 132 | MAPK12 | 0.60669363 |
| 133 | SGK2 | 0.60584084 |
| 134 | KSR1 | 0.59900982 |
| 135 | PIM1 | 0.59674554 |
| 136 | LATS2 | 0.58269219 |
| 137 | EIF2AK2 | 0.58225431 |
| 138 | EEF2K | 0.57465457 |
| 139 | TAOK2 | 0.57447202 |
| 140 | HIPK2 | 0.57134862 |
| 141 | ERBB2 | 0.57084847 |
| 142 | CLK1 | 0.56956204 |
| 143 | RIPK4 | 0.56133624 |
| 144 | DAPK1 | 0.55976658 |
| 145 | GSK3A | 0.55279007 |
| 146 | CSNK1G2 | 0.53584364 |
| 147 | FYN | 0.53327274 |
| 148 | IKBKE | 0.52280822 |
| 149 | TYK2 | 0.51726513 |
| 150 | SGK1 | 0.50878138 |
| 151 | PTK2B | 0.50111903 |
| 152 | FER | 0.49937987 |
| 153 | CDK2 | 0.48942440 |
| 154 | IRAK1 | 0.48610635 |
| 155 | MAP3K11 | 0.47137520 |
| 156 | MAPK3 | 0.46836394 |
| 157 | CAMK4 | 0.46381619 |
| 158 | MARK3 | 0.46348504 |
| 159 | LYN | 0.46216650 |
| 160 | EPHB2 | 0.46046935 |
| 161 | STK10 | 0.45904026 |
| 162 | ALK | 0.45624930 |
| 163 | CSNK1A1L | 0.44900077 |
| 164 | MAP3K8 | 0.44739947 |
| 165 | FGR | 0.42789991 |
| 166 | CHEK2 | 0.41942756 |
| 167 | TGFBR1 | 0.39669952 |
| 168 | RPS6KA1 | 0.39317087 |
| 169 | VRK2 | 0.39206630 |
| 170 | RPS6KB1 | 0.38959494 |
| 171 | MKNK1 | 0.38567901 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.23596497 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.91644336 |
| 3 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.52753323 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.51376710 |
| 5 | Other glycan degradation_Homo sapiens_hsa00511 | 2.48300429 |
| 6 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.43181062 |
| 7 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.41834683 |
| 8 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.39279869 |
| 9 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 2.26281139 |
| 10 | DNA replication_Homo sapiens_hsa03030 | 2.13879994 |
| 11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.07666282 |
| 12 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.00473049 |
| 13 | Asthma_Homo sapiens_hsa05310 | 1.99225693 |
| 14 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.94870188 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.90886324 |
| 16 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.89456886 |
| 17 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.84858667 |
| 18 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.79649642 |
| 19 | Leishmaniasis_Homo sapiens_hsa05140 | 1.78128288 |
| 20 | Allograft rejection_Homo sapiens_hsa05330 | 1.77830290 |
| 21 | Bile secretion_Homo sapiens_hsa04976 | 1.75944375 |
| 22 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.75886811 |
| 23 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.73820896 |
| 24 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.72594596 |
| 25 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.70794678 |
| 26 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.70515901 |
| 27 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.68478509 |
| 28 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.64997982 |
| 29 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.63706003 |
| 30 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.60437998 |
| 31 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.58001137 |
| 32 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.57092995 |
| 33 | Platelet activation_Homo sapiens_hsa04611 | 1.47702254 |
| 34 | Base excision repair_Homo sapiens_hsa03410 | 1.47255157 |
| 35 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.47024949 |
| 36 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.41391206 |
| 37 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.41216214 |
| 38 | Hepatitis B_Homo sapiens_hsa05161 | 1.40008343 |
| 39 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.39761129 |
| 40 | Viral myocarditis_Homo sapiens_hsa05416 | 1.36274399 |
| 41 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.35916816 |
| 42 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.34771787 |
| 43 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.33940676 |
| 44 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.33633592 |
| 45 | Influenza A_Homo sapiens_hsa05164 | 1.32113292 |
| 46 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.31622335 |
| 47 | Bladder cancer_Homo sapiens_hsa05219 | 1.31455444 |
| 48 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.30863992 |
| 49 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.29975415 |
| 50 | Measles_Homo sapiens_hsa05162 | 1.29828030 |
| 51 | Thyroid cancer_Homo sapiens_hsa05216 | 1.26069121 |
| 52 | Colorectal cancer_Homo sapiens_hsa05210 | 1.21680163 |
| 53 | Peroxisome_Homo sapiens_hsa04146 | 1.20385474 |
| 54 | ABC transporters_Homo sapiens_hsa02010 | 1.20019841 |
| 55 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.19691214 |
| 56 | Lysine degradation_Homo sapiens_hsa00310 | 1.17404360 |
| 57 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.16251358 |
| 58 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.16184675 |
| 59 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.15161919 |
| 60 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.14851135 |
| 61 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.14663795 |
| 62 | Spliceosome_Homo sapiens_hsa03040 | 1.14428531 |
| 63 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.13145376 |
| 64 | HTLV-I infection_Homo sapiens_hsa05166 | 1.10467675 |
| 65 | RNA transport_Homo sapiens_hsa03013 | 1.07870329 |
| 66 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.07544896 |
| 67 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.06437773 |
| 68 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.05611106 |
| 69 | Histidine metabolism_Homo sapiens_hsa00340 | 1.04668957 |
| 70 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.04663668 |
| 71 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.04049223 |
| 72 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.03771706 |
| 73 | Endometrial cancer_Homo sapiens_hsa05213 | 1.03747978 |
| 74 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.01590438 |
| 75 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.01419922 |
| 76 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.98806833 |
| 77 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.97794916 |
| 78 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.97120697 |
| 79 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.96228814 |
| 80 | Hepatitis C_Homo sapiens_hsa05160 | 0.94781150 |
| 81 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.94492512 |
| 82 | Prostate cancer_Homo sapiens_hsa05215 | 0.93919503 |
| 83 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.93767994 |
| 84 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.93709186 |
| 85 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.93457180 |
| 86 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.92764503 |
| 87 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.92541677 |
| 88 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.90803202 |
| 89 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.90741923 |
| 90 | Cell cycle_Homo sapiens_hsa04110 | 0.90078530 |
| 91 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.89448196 |
| 92 | Tuberculosis_Homo sapiens_hsa05152 | 0.88599015 |
| 93 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.88159737 |
| 94 | Shigellosis_Homo sapiens_hsa05131 | 0.87709286 |
| 95 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.86159855 |
| 96 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.85580304 |
| 97 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.84456546 |
| 98 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.83846431 |
| 99 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.83829384 |
| 100 | Insulin resistance_Homo sapiens_hsa04931 | 0.83530091 |
| 101 | Ribosome_Homo sapiens_hsa03010 | 0.83312383 |
| 102 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.82359880 |
| 103 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.81844446 |
| 104 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.81575724 |
| 105 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.81138176 |
| 106 | Apoptosis_Homo sapiens_hsa04210 | 0.79634472 |
| 107 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.79306555 |
| 108 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.78788058 |
| 109 | Insulin secretion_Homo sapiens_hsa04911 | 0.78416771 |
| 110 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.77741373 |
| 111 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.76947716 |
| 112 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.76899738 |
| 113 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.76340238 |
| 114 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.75414399 |
| 115 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.75355999 |
| 116 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.74815977 |
| 117 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.72972835 |
| 118 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.72955542 |
| 119 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.71658511 |
| 120 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.71547857 |
| 121 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.71119263 |
| 122 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.70705756 |
| 123 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.69813053 |
| 124 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.68176403 |
| 125 | Prion diseases_Homo sapiens_hsa05020 | 0.67893008 |
| 126 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.67371687 |
| 127 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.66552370 |
| 128 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.65074203 |
| 129 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.64863735 |
| 130 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.63308250 |
| 131 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.62240825 |
| 132 | Lysosome_Homo sapiens_hsa04142 | 0.62161168 |
| 133 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.61726861 |
| 134 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.61360806 |
| 135 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.60970894 |
| 136 | GABAergic synapse_Homo sapiens_hsa04727 | 0.59200283 |
| 137 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.59185466 |
| 138 | Salivary secretion_Homo sapiens_hsa04970 | 0.58948145 |
| 139 | Mismatch repair_Homo sapiens_hsa03430 | 0.58276126 |
| 140 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.58034346 |
| 141 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.57504579 |
| 142 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.57425927 |
| 143 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.56615280 |
| 144 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.56591245 |
| 145 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.56585610 |
| 146 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.55698674 |
| 147 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.54341339 |
| 148 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.53272284 |
| 149 | Carbon metabolism_Homo sapiens_hsa01200 | 0.52980510 |
| 150 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.52898625 |
| 151 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.52057207 |
| 152 | Retinol metabolism_Homo sapiens_hsa00830 | 0.51972854 |
| 153 | Renin secretion_Homo sapiens_hsa04924 | 0.51753152 |
| 154 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.50937510 |
| 155 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.50838416 |
| 156 | Focal adhesion_Homo sapiens_hsa04510 | 0.50767146 |
| 157 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.50335516 |
| 158 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.49946823 |
| 159 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.49677223 |
| 160 | Cocaine addiction_Homo sapiens_hsa05030 | 0.49666494 |
| 161 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.47781413 |
| 162 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.47108900 |
| 163 | Circadian entrainment_Homo sapiens_hsa04713 | 0.46533427 |
| 164 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.46368560 |
| 165 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.46111790 |
| 166 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.45211065 |
| 167 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.44070294 |
| 168 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.44066078 |
| 169 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.43881046 |
| 170 | Long-term potentiation_Homo sapiens_hsa04720 | 0.43529748 |
| 171 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.42988467 |
| 172 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.41637491 |
| 173 | Glioma_Homo sapiens_hsa05214 | 0.41623543 |
| 174 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.41475454 |
| 175 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.40090383 |
| 176 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.39935428 |
| 177 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.37431161 |
| 178 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.37404845 |
| 179 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.37397521 |
| 180 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.37061697 |
| 181 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.36704286 |
| 182 | Morphine addiction_Homo sapiens_hsa05032 | 0.36083607 |
| 183 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.35544106 |
| 184 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.34901768 |
| 185 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.34811052 |

